General Manager and Chief Technology Officer, Sequanta Technologies Co., Ltd.
BIOGRAPHY
Speaker
Event Date & Time
Date: April 23, 2025
Time: 4:00 PM (CST), 9:00 AM (CEST), 1:00 AM (PDT)
Abstract
Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics, played a key role in a Phase III clinical trial.
Using the Olink® Explore 3072 proteomics platform, researchers identified a unique 15-protein signature that helps predict which patients are more likely to respond to chemotherapy treatment. Patients with higher scores in this signature showed longer survival and better treatment outcomes.
The study also integrated genomics data revealing gene mutation and pathways correlated with enhanced treatment response.
Join this webinar to learn:
- How multiomics approach can improve clinical trial decision-making in oncology.
- How proteomics and genomics identified predictive and prognostic biomarkers to improve immunotherapy outcomes in small cell lung cancer.
- How CLIA/CAP/ISO15189-certified multiomics services can support high-impact biomarker research in oncology clinical trials.
Organized in collaboration with 
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
APR 21, 2025 | 1:00 PM
C.E. CREDITS
Routine coagulation assays are widely performed in laboratories and provide valuable information to the patient’s overall clinical picture. It’s important for laboratorians to kn...
FEB 25, 2025 | 1:00 PM
C.E. CREDITS
Quality efforts in the clinical laboratory are always under the microscope- a hyper-focus for laboratorians from start to finish. Recognizing the external factors that affect hemostasis test...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
MAR 19, 2025 | 11:30 AM
Join this year's poster presenters in the Poster Hall during the Poster Networking Hour, Wednesday, March 5th, from 10:00 –11:00 AM PDT , to chat...
Loading Comments...